Carlos F. Caceres

Carlos F. Caceres

Auto-generated profile, based on publicly available information

Carlos F. Caceres

Centro de Investigación Interdisciplinaria en Sexualidad, Sida y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in The Lancet
Verified
Journal Article
Closed access
TCThomas J Coates
Thomas J Coates
LRLinda Richter
Linda Richter
CCCarlos Caceres
Carlos Caceres

11 July 2011 in Global Public Health
Verified
Journal Article
Closed access
JAJudith D. Auerbach
Judith D. Auerbach
JPJustin O. Parkhurst
Justin O. Parkhurst
CCCarlos F. Cáceres
Carlos F. Cáceres
A key component of the shift from an emergency to a long-term response to AIDS is a change in focus from HIV prevention interventions focused on individuals to a comprehensive strategy in which social/structural approaches are core elements. Such approaches aim to modify social conditions by addressing key drivers of HIV vulnerability that affect the ability of individuals to protect themselves and others from HIV. The development and implementation of evidence-based social/structural interventions have been hampered by both scientific and political obstacles that have not been fully explored or redressed. This paper provides a framework, examples, and some guidance for how to conceptualise, operationalise, measure, and evaluate complex social/structural approaches to HIV prevention to help situate them more concretely in a long-term strategy to end AIDS.

17 July 2015 in AIDS
Verified
Journal Article
Closed access
JHJessica E. Haberer
Jessica E. Haberer
DBDavid R. Bangsberg
David R. Bangsberg
JBJared M. Baeten
Jared M. Baeten
KCKathryn Curran
Kathryn Curran
FKFlorence Koechlin
Florence Koechlin
KOKevin O’rEilly
Kevin O’rEilly
Clinical trial data have shown that oral pre-exposure prophylaxis (PrEP) is efficacious when taken as prescribed; however, PrEP adherence is complex and must be understood within the context of variable risk for HIV infection and use of other HIV prevention methods. Different levels of adherence may be needed in different populations to achieve HIV prevention, and the optimal methods for achieving the necessary adherence for both individual and public health benefits are unknown. Guidance for PrEP use must consider these questions to determine the success of PrEP-based HIV prevention programs. In this article, we propose a new paradigm for understanding and measuring PrEP adherence, termed prevention-effective adherence, which incorporates dynamic HIV acquisition risk behaviors and the use of HIV alternative prevention strategies. We discuss the need for daily PrEP use only during periods of risk for HIV exposure, describe key issues for measuring and understanding relevant behaviors, review lessons from another health prevention field (i.e., family planning), and provide guidance for prevention-effective PrEP use. Moreover, we challenge emerging calls for sustained, near perfect PrEP adherence regardless of risk exposure and offer a more practical and public health-focused vision for this prevention intervention.

1 January 2015 in The Lancet
Verified
Journal Article
Closed access
SBStefan David Baral
Stefan David Baral
MFM Reuel Friedman
M Reuel Friedman
SGScott Geibel
Scott Geibel
KRKevin Rebe
Kevin Rebe
BBBorche Bozhinov
Borche Bozhinov
CCCarlos F Cáceres
Carlos F Cáceres

8 October 2011 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
ASAlfonso Silva-Santisteban
Alfonso Silva-Santisteban
HRH. Fisher Raymond
H. Fisher Raymond
XSXimena Salazar
Ximena Salazar
JVJana Villayzan
Jana Villayzan
SLSegundo Ramos Leon
Segundo Ramos Leon
CCCarlos F. Caceres
Carlos F. Caceres

16 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJeffrey Lazarus
Jeffrey Lazarus
KSKelly Safreed-Harmon
Kelly Safreed-Harmon
AKAdeeba Kamarulzaman
Adeeba Kamarulzaman
JAJane Anderson
Jane Anderson
RLRicardo Baptista Leite
Ricardo Baptista Leite
LWLaura Waters
Laura Waters
Health systems have improved their abilities to identify, diagnose, treat and, increasingly, achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a higher burden of multimorbidity and poorer health-related quality of life are reported by many PLHIV in comparison to people without HIV. Stigma and discrimination further exacerbate these poor outcomes. A global multidisciplinary group of HIV experts developed a consensus statement identifying key issues that health systems must address in order to move beyond the HIV field’s longtime emphasis on viral suppression to instead deliver integrated, person-centered healthcare for PLHIV throughout their lives.